High plasma interleukin-2: a potential cause of insulin resistance
Related Experiment Video
Updated: Nov 4, 2026

Differentiated Mouse Adipocytes in Primary Culture: A Model of Insulin Resistance
Published on: February 17, 2023
1Kuopio Regional Institute of Occupational Health, Finland.
Abstract:
Low-density lipoproteins, infections and smoking are closely associated with insulin resistance. According to the hypothesis proposed in this paper, all of these factors could cause insulin resistance by the same mechanism. The first step in the cascade of events leading to insulin resistance is increased production of interleukin-2. This is followed by secretion of other cytokines, activation of macrophages and increased production of nitric oxide from L-arginine. The reduced amount of plasma L-arginine leads to decreased secretion of growth hormone and insulin-like growth factor-1 during exercise. The decreased secretion of insulin-like growth factor-1 is the basic reason for insulin resistance. Tumour necrotizing factor may also be involved in the pathogenesis of insulin resistance directly by binding in beta-adrenergic receptors. High plasma interleukin-2 also causes decreased bioavailability of insulin-like growth factor-1 by reducing the production of androgenic hormones.
Related Concept Videos
Insulin: The Receptor and Signaling Pathways
Type I Diabetes II: Pathophysiology
Type II Diabetes II: Pathophysiology
Type II Diabetes I: Introduction
Dipeptidyl Peptidase 4 Inhibitors
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
